Edward C. Chao

SGLT-2 Inhibitors: A New Mechanism for Glycemic Control

Edward C. Chao · Clinical Diabetes · 2014 · 197 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Extended Noninvasive Glucose Monitoring in the Interstitial Fluid Using an Epidermal Biosensing Patch

Ernesto De la Paz, Abbas Barfidokht, Samantha Rios et al. · Analytical Chemistry · 2021 · 116 citations

Engineering, Bioengineering, Biomedical Engineering +17

A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.

Edward C. Chao · PubMed · 2011 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes

Sunder Mudaliar, Anna Chang, Vanita R. Aroda et al. · Diabetes Obesity and Metabolism · 2009 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +17

Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes

Edward C. Chao · Core evidence · 2012 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17